Drug Trial Radar · NCT06178367
Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment
Last checked: Nov 20, 2026Latest source record: Apr 30, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
36
Actual
Start
Aug 26, 2023
Primary completion
Sep 30, 2023
Study completion Sep 30, 2023
Sponsor
- Lead sponsor
- Universitas IndonesiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 21, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 60 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to compare 0,1% topical low molecular weight (7 kDa) hyaluronic acid with 0,1% high molecular weight (1.800 kDa) hyaluronic acid as therapy of xerotic skin in elderly
Conditions
- Xerosis Cutis
Interventions
Low molecular weight hyaluronic acidDrug
Topical 0,1% low molecular weight (7 kDa) hyaluronic acid in vehicle
High molecular weight hyaluronic acidDrug
Topical 0,1% high molecular weight (1.800 kDa) hyaluronic acid in vehicle
VehicleDrug
Vehicle ingredients including aqua, paraffinum liquidum, glycerin, petrolatum, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, arachidyl alcohol, squalane, behenyl alcohol, phenoxyethanol, arachidyl glucoside, allantoin, chlorphenesin, and disodium EDTA
Primary outcomes
What the sponsor says the trial is designed to measure.
- Skin capacitanceTime frame: 2 weeks and 4 weeks
- Transepidermal water lossTime frame: 2 weeks and 4 weeks
- Specified symptom sum score/scale, roughness, redness, crack (SRRC)Time frame: 2 weeks and 4 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Panti Sosial Tresna Werdha Budi Mulia 3
Jakarta, DKI Jakarta, Indonesia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.